Hofseth Biocare ASA
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC"), has today purchased 70,000 shares in HBC at an average price of NOK 9.294 per share.
As a result of the transaction, Mr. Baldegger holds 650,000 shares in HBC, equal to 0.18 % of the outstanding shares.
This information is subject of the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
INTESA SANPAOLO S.P.A.12.7.2025 10:07:31 CEST | Press release
Papanicolaou outlines Intesa Sanpaolo’s commitment to rebuilding Ukraine
Bitget Limited12.7.2025 07:17:59 CEST | Press release
Bitget Launchpool to List Chainbase (C) with 2.75M in Token Rewards
Ingredion Incorporated11.7.2025 22:03:00 CEST | Press release
Ingredion to Release 2025 Second Quarter Financial Results On August 1, 2025
Strategic Partners A/S11.7.2025 21:58:13 CEST | Pressemeddelelse
Ledende medarbejders transaktion
Brookfield Corporation11.7.2025 19:45:09 CEST | Press release
Brookfield Corporation to Host Second Quarter 2025 Results Conference Call
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom